This inventor holds 1 USPTO granted patent. Top assignee: Dong-A St Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovator Hyo Ju Lee: Pioneering GPR119 Agonistic Activity
Introduction: Hyo Ju Lee, an accomplished inventor based in Gyeonggi-do, South Korea, has made significant contributions to the field of pharmaceuticals. He is recognized for his innovative approach to developing new compounds that can positively affect human health.
Latest Patents: Hyo Ju Lee holds one notable patent titled "Substituted piperidines having GPR119 agonistic activity." This invention relates to substituted piperidines represented by a specific chemical formula, which exhibit GPR119 agonistic activity. The patent outlines a method for preparing these compounds and details a pharmaceutical composition that includes them.
Career Highlights: Currently, Hyo Ju Lee is employed by Dong-A ST Co., Ltd., where he contributes his expertise to the company's research and development initiatives. His work focuses on innovative pharmaceutical solutions that enhance therapeutic efficacy.
Collaborations: Throughout his career, Hyo Ju Lee has collaborated closely with other talented professionals in his field, including colleagues Jae Sung Yang and Gye Rim Baek, fostering a productive environment for scientific advancement.
Conclusion: Hyo Ju Lee stands as a testament to the power of innovation in the pharmaceutical industry. His patent on GPR119 agonistic activity paves the way for future research and development, showcasing the vital role of inventors in pushing the boundaries of health science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile